5 nov 2019
CPhI Worldwide 2019
Raptim Research Ltd

Raptim Research Ltd

Exhibitor at CPhI Worldwide 2019 stand 121B54, CRO & Clinical Trials Zone

About us

Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. The studies done at Raptim are globally submitted and approved by various regulatory agencies including USFDA, EMA, UK MHRA, Canada (TPD), WHO and etc.
Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA. Raptim is leader following activities:

  • Bioequivalence / Bioavailability Studies (BE/BA studies)
  • PK end-point studies
  • PD end-point studies
  • Clinical trials – phase II & IV
  • Studies on Special Population
Apart from the above, Raptim has developed expertise in niche area of drug development and has pioneered in testing/screening Dermal Topical Products including Cosmetic Products as well as inhalation products. These include:

  • In vitro Release/Permeation (IVRT/IVPT) studies 
  • In vivo – Tape Stripping studies
  • In vivo – Dermal Micro Dialysis
  • Skin Blanching Studies – measurement of Vasoconstriction Assay
  • Skin Irritation and sensitization studies
  • Studies with inhalers

Specs about this supplier

Affiliated categories: Bioanalysis |Clinical Research (Field) |Clinical Trials Phase I to IV More

Products featured at CPhI Worldwide 2019

Raptim Research Ltd

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 121B54